THE CHEKING PROCESS – Responsible for issuing marketing authorizations, the EMA’s experts must show their feet when it comes to links of interest. But difficulties remain.
THE QUESTION. She is responsible for whether or not to authorize vaccines against Sars-CoV-2 in the 27 countries of the European Union. On December 21, the European Medicines Agency (EMA, for European Medicines Agency) gave the green light to a first vaccine, that produced by Pfizer and BioNTech. On January 6, she is expected to render her decision on Moderna Therapeutics’ vaccine.
It will therefore have taken just a year between the identification of the virus and the availability of a vaccine. A record time, a source of joy for some, of doubts for others. In a context where access to vaccines crystallizes important political and economic issues, the question of the independence of health agencies arises. Does the EMA independently assess vaccines?
CHECKS. In recent weeks, officials from the European Medicines Agency have placed great emphasis on the seriousness and high level of independence of their work. “Our experts
This article is for subscribers only. You have 89% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Already subscribed? Log in